Avectas

3 results

Avectas cofounder and chief executive Dr Michael Maguire, with cofounder Dr Shirley O’Dea, chief scientific officer and business development director Dr Gillian Hendy. Photograph: Iain White/Fennells

Serial entrepreneur Seamus Mulligan has led a $10 million (€12 million) fundraising for an Irish business at the cutting edge of cell therapy. Avect(...)

Adapt Pharma developed a non-injectable form of Naloxone,  which resulted in a $735 million payday for its investors,  including serial pharmaceutical entrepreneur Séamus Mulligan

You’d never say that a $735 million payday was not a landmark occasion but the sale of Adapt Pharma – the maker of the opioid rescue drug Narcan that (...)

Dr Michael Maguire with fellow directors Dr Gillian Hendy and Dr Shirley O’Dea

An Irish company which has developed a transformative new technology for the manufacture of the latest cancer treatments has been awarded €2.1 million(...)